about
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the revers...
Read More
8.85
-0.35
(-3.80%)
139.2K
XNAS Volume
XNAS 12 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
CervoMed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..